InsidersTradesSigma
Baijin Life Science Holdings Ltd.: management transactions · Hong Kong · HKEX
HKEX:baijin-life-science-holdings-ltdHK·HKEXMcap 461M€Consumer Cyclical
Browse the full directors' dealings record of Baijin Life Science Holdings Ltd., a listed equity based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Consumer Cyclical sector, Baijin Life Science Holdings Ltd. has logged 9 insider filings. Market capitalisation: €461.5m. The latest transaction was reported on 29 April 2026 — Purchase. Among the most active insiders: CHENG Chi Kin. All data is free.
9
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
0.49 €
Analyst consensus
Income statement
Revenue135.6 M€
Gross profit42.0 M€31% margin
Net income−316 k€6.7% margin
Valuation
PER (trailing)49.5x
P/Book2.7x
Beta-0.25
Balance sheet & cash
Market cap461.5 M€
Total debt99.9 M€
Free Cash Flow−33.0 M€
Debt / Equity54%
Profitability & ownership
ROE3.3%
ROA1.2%
% insiders32.7%
% institutions0.0%
Last declaration on 29 April 2026
Declarations9 total
Executives●Purchase3HKEX
1,000,000 shares
ShareXHKG
HKEX:DA20260428E00528·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
932,000 shares
ShareXHKG
HKEX:DA20260428E00519·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
2,000,000 shares
ShareXHKG
HKEX:DA20260428E00340·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
2,933,765 shares
ShareXHKG
HKEX:DA20260429E00164·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
9,322,540 shares
ShareXHKG
HKEX:DA20260428E00086·
Ideal exit: 19 Jan 2027 (T+270)
Executives●Purchase3HKEX
932,000 shares
ShareXHKG
HKEX:DA20260428E00295·
Ideal exit: 19 Jan 2027 (T+270)
9 of 9 declarations